Attached files

file filename
8-K - 8-K - AMERICAN SCIENCE & ENGINEERING, INC.a13-24005_18k.htm

EXHIBIT 99.1

 

FOR IMMEDIATE RELEASE

 

American Science and Engineering, Inc. Reports Results for

Second Quarter Fiscal Year 2014 and Declares a Quarterly Dividend

 

·                  Earnings per Share Reported at $0.60

·                  Strong Operating Income Margin at 16%

·                  $16.5M of Free Cash Flow

 

BILLERICA, Mass. — November 12, 2013 — American Science and Engineering, Inc. (NASDAQ: ASEI) (“AS&E”), a leading worldwide supplier of innovative X-ray detection solutions, today reports its financial results for the second quarter of fiscal year 2014 ended September 30, 2013. The Company is reporting revenues of $43.8 million as compared with revenues of $46.3 million for the second quarter of fiscal year 2013, net income of $4.7 million as compared with net income of $6.4 million for the second quarter of fiscal year 2013, and earnings per share of $0.60 as compared with earnings per share of $0.76 for the second quarter of fiscal year 2013.

 

For the first six months of fiscal year 2014 ended September 30, 2013, the Company reported revenues of $86.9 million compared with revenues of $93.6 million for the same period in the prior fiscal year, net income of $9.6 million compared with net income of $10.6 million for the same period in the prior fiscal year, and earnings per share of $1.22 compared with earnings per share of $1.22 for the prior fiscal year.

 

The Company is reporting $45.8 million in bookings for the second quarter of fiscal year 2014 and $75.7 million for the first half of fiscal year 2014.  Backlog at September 30, 2013 was $175.0 million.

 

“We delivered solid financial performance at current business levels, as evidenced by strong operating income margin, free cash flow, and healthy EPS, said Chuck Dougherty, AS&E’s President and Chief Executive Officer. Additionally, we continued to strengthen our balance sheet with a quarter-end cash balance of $170 million.”

 

Dougherty continued, “I am encouraged with the progress we are making on our key growth initiatives. Of note are the twenty ZBV® systems booked in the second quarter — nineteen of which are with international customers in targeted growth markets — enhancing and expanding our global presence.  Our international pipeline, notably for the industry-leading ZBV platform, continues to strengthen.”

 

Continuing with its dividend program started in August 2007, the Company is declaring a quarterly cash dividend of $0.50 per share, payable on December 2, 2013 to the holders of record at the close of business on November 20, 2013.

 

Chuck Dougherty, President and Chief Executive Officer, and Ken Galaznik, Senior Vice President, Chief Financial Officer and Treasurer, will host a conference call and simultaneous audio webcast on Tuesday, November 12, 2013 at 8:30 a.m. ET to discuss the results and respond to questions.  To participate in the conference call, please dial 1-877-303-9143 at least 10 minutes prior to its starting time. For international participants, please dial 1-760-536-5194. The conference identification number is 93528160. You will be placed on hold until the conference call is ready to begin.  The live audio webcast can be accessed through the investor relations section of the Company’s website at http://ir.as-e.com/events.cfm.

 

An audio replay of the teleconference will be available, in its entirety, starting Tuesday November 12, 2013 at 11:30 a.m. ET for a one-week period by dialing 1-855-859-2056. Internationally, please dial 1-404-537-3406. The conference identification number is 93528160. The replay will also be available through the Company’s web site at http://ir.as-e.com/events.cfm.

 

About AS&E

 

American Science and Engineering, Inc. (AS&E) is the trusted global provider of threat and contraband detection solutions for ports, borders, military, critical infrastructure, law enforcement, and aviation. With over 50 years of experience, AS&E offers proven, advanced, X-ray inspection systems to combat terrorism, drug smuggling, illegal

 



 

immigration and trade fraud. AS&E systems are designed in a variety of configurations for cargo and vehicle inspection, parcel inspection, and personnel screening. Using a combination of technologies, these systems provide superior detection capabilities, with high-energy, dual-energy, and Z Backscatter X-rays — pioneered by AS&E. Learn more about AS&E products and technologies at www.as-e.com.

 

Investor Relations Contact:

 

Annemarie Sadowski

American Science and Engineering, Inc.

asadowski@as-e.com

978-262-8828

 

Safe Harbor Statement: The foregoing press release contains statements concerning AS&E’s financial performance, markets and business operations that may be considered “forward-looking” under applicable securities laws.  AS&E wishes to caution readers of this press release that actual results might differ materially from those projected in any forward-looking statements. Factors which might cause actual results to differ materially from those projected in the forward-looking statements contained herein include the following: significant reductions, delays or cancellations (in full or in part) in procurements of the Company’s systems by the United States and other governments; disruption in the supply of any source component incorporated into AS&E’s products; litigation seeking to restrict the use of intellectual property used by the Company; limitations under certain laws on the Company’s ability to protect its own intellectual property; potential product liability claims against the Company; global political trends and events which affect public perception of the threat presented by drugs, explosives and other contraband; global economic developments and the ability of governments and private organizations to fund purchases of the Company’s products to address such threats; the potential insufficiency of Company resources, including human resources, capital, plant and equipment and management systems, to accommodate any future growth; technical problems and other delays that could impact new product development and the Company’s ability to adapt to changes in technology and customer requirements; competitive pressures; lengthy sales cycles both in United States government procurement and procurement abroad;  future delays in federal funding, the market price of the company’s stock prevailing from time to time, the nature of other investment opportunities presented to the company from time to time,  the company’s cash flows from operations and market and general economic conditions. These and certain other factors which might cause actual results to differ materially from those projected are detailed from time to time in AS&E’s periodic reports and registration statements filed with the Securities and Exchange Commission, which important factors are incorporated herein by reference. AS&E undertakes no obligation to update forward looking statements to reflect changed assumptions, the occurrence of unanticipated events, or changes in future operating results, financial condition or business over time. Readers are further advised to review the “Risk Factors” set forth in the Company’s most recent Form 10-Q and Form 10-K,  which further detail and supplement the factors described in this Safe Harbor Statement.  Among other disclosures, the Risk Factors disclose risks pertaining to that portion of the Company’s business that is dependent on United States government contracting as well as international customers.

 



 

AMERICAN SCIENCE AND ENGINEERING, INC.

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

(in thousands, except per share amounts)

(unaudited)

 

 

 

Quarter Ended

 

Six Months Ended

 

 

 

September 30,
2013

 

September 30,
2012

 

September 30,
2013

 

September 30,
2012

 

Total net sales and contract revenues

 

$

43,816

 

$

46,253

 

$

86,900

 

$

93,597

 

 

 

 

 

 

 

 

 

 

 

Total cost of sales and contracts

 

24,610

 

25,256

 

48,547

 

51,127

 

Gross profit

 

19,206

 

20,997

 

38,353

 

42,470

 

 

 

 

 

 

 

 

 

 

 

Expenses:

 

 

 

 

 

 

 

 

 

Selling, general and administrative expenses

 

6,913

 

4,895

 

14,322

 

12,893

 

Research and development costs

 

5,172

 

6,505

 

9,586

 

13,620

 

Total operating expenses

 

12,085

 

11,400

 

23,908

 

26,513

 

 

 

 

 

 

 

 

 

 

 

Operating income

 

7,121

 

9,597

 

14,445

 

15,957

 

Interest and other income (expense), net

 

5

 

98

 

(3

)

105

 

Income before provision for income taxes

 

7,126

 

9,695

 

14,442

 

16,062

 

Provision for income taxes

 

2,387

 

3,296

 

4,838

 

5,461

 

 

 

 

 

 

 

 

 

 

 

Net income

 

$

4,739

 

$

6,399

 

$

9,604

 

$

10,601

 

 

 

 

 

 

 

 

 

 

 

Income per share - Basic

 

$

0.61

 

$

0.77

 

$

1.23

 

$

1.23

 

Income per share - Diluted

 

$

0.60

 

$

0.76

 

$

1.22

 

$

1.22

 

 

 

 

 

 

 

 

 

 

 

Weighted average shares - Basic

 

7,820

 

8,364

 

7,831

 

8,609

 

Weighted average shares - Diluted

 

7,851

 

8,418

 

7,866

 

8,662

 

 

The results of operations reported herein may not be indicative of future financial conditions or results of future operations.

 



 

AMERICAN SCIENCE AND ENGINEERING, INC.

CONDENSED CONSOLIDATED BALANCE SHEETS

(in thousands)

(unaudited)

 

 

 

September 30, 2013

 

March 31, 2013

 

Assets

 

 

 

 

 

Current assets:

 

 

 

 

 

Cash and cash equivalents

 

$

86,469

 

$

40,418

 

Restricted cash and investments

 

13,878

 

12,618

 

Short-term investments, at fair value

 

68,501

 

108,546

 

Accounts receivable, net

 

21,019

 

28,477

 

Unbilled costs and fees

 

4,870

 

4,875

 

Inventories, net

 

50,808

 

48,051

 

Other current assets

 

8,747

 

11,984

 

Total current assets

 

254,292

 

254,969

 

 

 

 

 

 

 

Non-current assets:

 

 

 

 

 

Building, equipment and leasehold improvements, net

 

15,087

 

16,451

 

Restricted cash and investments

 

861

 

899

 

Other assets

 

8,833

 

9,130

 

Total assets

 

$

279,073

 

$

281,449

 

 

 

 

 

 

 

Liabilities & Stockholders’ Equity

 

 

 

 

 

Current liabilities:

 

 

 

 

 

Accounts payable

 

$

11,244

 

$

8,371

 

Customer deposits

 

28,930

 

16,199

 

Deferred revenue

 

13,974

 

15,770

 

Other current liabilities

 

22,361

 

28,148

 

Total current liabilities

 

76,509

 

68,488

 

 

 

 

 

 

 

Non-current liabilities:

 

 

 

 

 

Lease financing liability

 

2,161

 

2,914

 

Other non-current liabilities

 

4,469

 

5,802

 

Total liabilities

 

83,139

 

77,204

 

 

 

 

 

 

 

Stockholders’ equity

 

195,934

 

204,245

 

Total liabilities and stockholders’ equity

 

$

279,073

 

$

281,449

 

 



 

AMERICAN SCIENCE AND ENGINEERING, INC.

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

(in thousands)

(unaudited)

 

 

 

For the Six Months Ended

 

 

 

September 30,
2013

 

September
30, 2012

 

Cash flows from operating activities:

 

 

 

 

 

Net income

 

$

9,604

 

$

10,601

 

Adjustments to reconcile net income to net cash provided by operating activities:

 

 

 

 

 

Depreciation and amortization

 

2,613

 

2,535

 

Provisions for contracts, inventory and accounts receivable reserves

 

1,543

 

1,223

 

Amortization of bond premium

 

855

 

1,486

 

Deferred income taxes

 

1,894

 

 

Stock compensation expense (credit)

 

641

 

(104

)

 

 

 

 

 

 

Changes in assets and liabilities:

 

 

 

 

 

Accounts receivable

 

7,490

 

(2,404

)

Unbilled costs and fees

 

5

 

366

 

Inventories

 

(4,332

)

(226

)

Prepaid expenses and other assets

 

1,640

 

613

 

Accounts payable

 

2,873

 

(897

)

Accrued income taxes

 

(2,094

)

991

 

Customer deposits

 

12,731

 

6,309

 

Deferred revenue

 

(3,077

)

(3,934

)

Accrued expenses and other liabilities

 

(3,756

)

(1,234

)

Net cash provided by operating activities

 

28,630

 

15,325

 

 

 

 

 

 

 

Cash flows from investing activities:

 

 

 

 

 

Purchases of short-term investments

 

(18,311

)

(53,362

)

Proceeds from sales and maturities of short-term investments

 

57,534

 

96,540

 

Purchases of property and equipment, net

 

(1,249

)

(2,007

)

Net cash provided by investing activities

 

37,974

 

41,171

 

 

 

 

 

 

 

Cash flows from financing activities:

 

 

 

 

 

Increase in restricted cash and investments

 

(1,222

)

(1,348

)

Proceeds from exercise of stock options

 

1,497

 

282

 

Repurchase of shares of common stock

 

(12,306

)

(34,967

)

Repayment of leasehold financing liability

 

(742

)

(667

)

Payment of common stock dividend

 

(7,800

)

(8,621

)

Reduction of income taxes paid due to the tax benefit from employee stock option expense

 

20

 

 

Net cash used for financing activities

 

(20,553

)

(45,321

)

 

 

 

 

 

 

Net increase in cash and cash equivalents

 

46,051

 

11,175

 

Cash and cash equivalents at beginning of period

 

40,418

 

24,369

 

Cash and cash equivalents at end of period

 

$

86,469

 

$

35,544

 

 

-####-